Ionis Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ISI.F | ARWR | ALNY | BBIO | DNLI | PTCT | |
|---|---|---|---|---|---|---|
| Market cap | 6.69B | 8.31B | 30.12B | 13.24B | 2.99B | 5.23B |
| P/E (TTM) | — | — | 38.0 | — | — | — |
| Forward P/E | -22.9 | -11.8 | 18.2 | -301.6 | -7.7 | 26.4 |
| Price/book | 17.0 | 17.8 | 22.2 | -5.3 | 3.6 | -31.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −36.06% | +57.54% | −51.49% | +25.89% | +17.63% | −6.26% |
| Today | +2.73% | −0.14% | −2.43% | +0.28% | −1.32% | −0.48% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ISI.F news ›Lobbying Update: $150,000 of IONIS PHARMACEUTICALS INC. lobbying was just disclosed
$150,000 of IONIS PHARMACEUTICALS INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. IONS insiders have traded $IONS stock on the open market 29 times in the past 6 months. Of those trades, 2 have…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
themarketsdaily.com2
-
moomoo.com1
-
quiverquant.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.